The SVA chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the SVA chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The SVA stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
View SVA Detailed Price Forecast - CNN Money | View SVA Detailed Summary - Google Finance | ||
View SVA Detailed Summary - Yahoo! Finance | View SVA Stock Research & Analysis - Zacks.com |
View SVA Trends & Analysis - Trade-Ideas | View SVA Major Holders - Barrons | ||
View SVA Call Transcripts - NASDAQ | View SVA Breaking News & Analysis - Seeking Alpha | ||
View SVA Annual Report - CompanySpotlight.com | View SVA OTC Short Report - OTCShortReport.com | ||
View SVA Fundamentals - TradeKing | View SVA SEC Filings - Bar Chart | ||
View Historical Prices for SVA - The WSJ | View Performance/Total Return for SVA - Morningstar | ||
View the Analyst Estimates for SVA - MarketWatch | View the Earnings History for SVA - CNBC | ||
View the SVA Earnings - StockMarketWatch | View SVA Buy or Sell Recommendations - MacroAxis | ||
View the SVA Bullish Patterns - American Bulls | View SVA Short Pain Metrics - ShortPainBot.com |
View SVA Stock Mentions - StockTwits | View SVA Stock Mentions - PennyStockTweets | ||
View SVA Stock Mentions - Twitter | View SVA Investment Forum News - Investor Hub | ||
View SVA Stock Mentions - Yahoo! Message Board | View SVA Stock Mentions - Seeking Alpha |
View Insider Transactions for SVA - SECform4.com | View Insider Transactions for SVA - Insider Cow | ||
View SVA Major Holdings Summary - CNBC | View Insider Disclosure for SVA - OTC Markets | ||
View Insider Transactions for SVA - Yahoo! Finance | View Institutional Holdings for SVA - NASDAQ |
View SVA Stock Insight & Charts - FinViz.com | View SVA Investment Charts - StockCharts.com | ||
View SVA Stock Overview & Charts - BarChart | View SVA User Generated Charts - Trading View |
Sinovac Amends Shareholder Rights Plan
Posted on Tuesday February 20, 2024
BEIJING, February 21, 2024--Sinovac Biotech Ltd. ("Sinovac" or the "Company") (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that its board of directors has amended its shareholder rights plan. The amendment extends the expiration date of the plan from February 22, 2024 to February 22, 2025.
Sinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender Offer
Posted on Thursday January 18, 2024
BEIJING, January 18, 2024--Sinovac Biotech Ltd. (NASDAQ: SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, announced today that its Board of Directors (the "Board of Directors") unanimously determined that the partial tender offer (the "Tender Offer") by Alternative Liquidity Index LP ("Alternative Liquidity") to acquire up to 10,000,000 common shares of Sinovac (the "Shares") for $0.03 per share in cash (the "Offer Price") is NOT advisable and is NOT
SINOVAC Reports on the Clinical Trial Progress of its Anti-COVID-19 Antibody SA55 Injection
Posted on Monday September 11, 2023
BEIJING, September 11, 2023--Sinovac Biotech Ltd. ("SINOVAC" or the "Company") (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that the Company has completed the phase I clinical trial for its broad-spectrum neutralizing antibody product, the Anti-COVID-19 Antibody SA55 Injection ("SA55 Injection") in Beijing and has entered the phase II clinical trial in Shanghai after successfully enrolling its first participant recently.
Sinovac Confirms Receipt of an Unsolicited Partial Tender Offer
Posted on Tuesday August 29, 2023
BEIJING, August 29, 2023--Sinovac Biotech Ltd. (NASDAQ: SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, confirmed today that it is aware of an unsolicited partial tender offer from Alternative Liquidity Index LP to purchase up to a maximum of 10,000,000 shares of the Company, representing approximately 10.05% of the Company’s outstanding shares, for $0.03 per share in cash.